HPV vaccine

Obstetrics, Gynaecology and Reproductive Medicine

Volumn 19, Issue 1, 2009, Pages 26-28

  Kyrgiou, Maria ^a,b   Shafi, Mahmood I ^a,b  

^a CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

cervical cancer; cervical intraepithelial neoplasia (CIN); human papillomavirus (HPV); primary prevention; public health; vaccine

Indexed keywords

PLACEBO; WART VIRUS VACCINE;

ARTICLE; CARCINOGENESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; FEVER; HUMAN; INJECTION SITE IRRITATION; PREVENTIVE HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CANCER; WART VIRUS;

EID: 57649112058     PISSN: 17517214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogrm.2008.09.010     Document Type: Article

References (5)

1. M. Arbyn J. Dillner Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening J Clin Virol 38 2007 189 197
2. J. Ferlay F. Bray P. Pisani D.M. Parkin GLOBOCAN 2004 Cancer incidence, mortality and prevalence worldwide IARC Cancer Base No. 5, Version 2.0 2004 IARC Press Lyon
3. N. Munoz F.X. Bosch X. Castellsague Against which human papillomavirus types shall we vaccinate and screen? The international perspective Int J Cancer 111 2004 278 285
4. Royal College of Obstetricians and Gynaecologists Vaccination against cervical cancer Scientific Advisory Committee Opinion Paper 9 2007 RCOG London
5. M. Stanley Prophylactic HPV vaccines J Clin Pathol 60 2007 961 965